REVO

Yeonje Ilsin Medical Center Director Jae Hyeok Jeong (left) and meerecompany Executive Vice President Ho Kun Lee (right) are taking a commemorative photo after signing a contract to introduce Revo-i.

meerecompany supplies surgical robot ‘Revo-i’ to Yeonje Ilsin Medical Center

– Yeonje Ilsin Medical Center, rich experience in obstetrics and gynecology diseases ‘expected to use robotic surgery for obstetrics and gynecology diseases’

– Continued expansion of domestic supply base in the first half of this year… Attention to successive achievements

meerecompany (CEO Joon Koo Kim) announced on the 7th that it would supply the surgical robot ‘Revo-i’ to Yeonje Ilsin Medical Center (Director Jae Hyeok Jeong). It is evaluated that this supply contract is a more meaningful achievement as it expands the base for treatment of women’s diseases.

Yeonje Ilsin Medical Center, located in Yeonje-gu, Busan, is a hospital with rich know-how and long experience in treating women’s diseases. The hospital performs high-level gynecological surgeries such as deep endometriosis surgery and adenomyosis surgery with excellent gynecological surgery staff and various university hospital-grade surgical equipment. In addition, by activating the National Health Screening Center, the Health Screening Center, General Screening Center, and Gastrointestinal Endoscopy Center were opened, and the only pediatric inpatient ward in the region is in operation.

Revo-i, which Yeonje Ilsin Medical Center decided to introduce this time, is a surgical robot developed and commercialized for the first time in Korea by meerecompany. It supports high-resolution 3D stereoscopic images, a wide field of view, and detailed movements through multi-joint instruments, so the surgeon can operate very comfortably and reduce the operation time. In addition, it is designed intuitively, so even first-time medical staff can learn it relatively easily. From the patient’s point of view, the risk of infection is low as the amount of blood loss is low, and the recovery period is short, so the patient can return to daily life quickly.

Through the introduction of Revo-i, Yeonje Ilsin Medical Center plans to actively apply robotic surgery to obstetrics and gynecology diseases based on its accumulated experience and provide quality medical services to patients. In addition, meerecompany’s strategy is to once again publicize the safety and effectiveness of Revo-i in the field of obstetrics and gynecology.

Yeonje Ilsin Medical Center Director Jae Hyeok Jeong said, “We expect that Yeonje Ilsin Medical Center’s ample surgical experience in the field of obstetrics and gynecology will create good synergy with the introduction of cutting-edge robotic surgical instruments and help patients. We will continue to strive to provide patient-centered, correct medical care.”

meerecompany CEO Joon Koo Kim said, “I am very pleased to be able to provide professional and systematic robotic surgery to patients in Busan with Yeonje Ilsin Medical Center. Above all, we will actively cooperate with hospitals so that patients can receive better treatment.”

Meanwhile, meerecompany’s Revo-i is taking a new leap forward this year. In the first half of this year, after signing a supply contract with Yeonje Ilsin Medical Center following the tertiary general hospital Severance Hospital and general hospital MYOUNGJU Hospital, it is expanding meaningful results in the domestic market.